Anti-AGO1 Antibodies Identify a Subset of Autoimmune Sensory Neuronopathy.

Christian Peter MoritzYannick TholancePierre-Baptiste VallayerLe Duy Do Sergio Muñiz-Castrillo Véronique RogemondKarine FerraudCoralie La MarcaJerome HonnoratMartin KillianStéphane PaulJean-Philippe CamdessanchéJean-Christophe G Antoine

Published in: Neurology(R) neuroimmunology & neuroinflammation (2023)

Although AGO Abs are not specific for SNN, based on our retrospective data, they may identify a subset of cases with SNN with more severe features and a possibly better response to IVIg. The significance of AGO1 Abs in clinical practice needs to be explored on a larger series.

Keyphrases

clinical practice
multiple sclerosis
cross sectional
electronic health record
early onset
machine learning
deep learning